omega-n-methylarginine has been researched along with Ascites in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyo, V; Fernández-Hernando, C; Fernández-Varo, G; Held, KF; Jiménez, W; Melgar-Lesmes, P; Morales-Ruiz, M; Pauta, M; Planas, AM; Ribera, J; Soria, G; Tudela, R; Tugues, S | 1 |
| Hayes, PC; Helmy, A; Jalan, R; Johnston, NR; Newby, DE; Webb, DJ | 1 |
| Jespersen, B; Schaffalitzky de Muckadell, OB; Skøtt, O; Thiesson, HC | 1 |
| Cardenas, A | 1 |
| Kwak, JY; Lee, NR; Sohn, MH; Song, EK; Yim, CY | 1 |
| Ferlitsch, A; Homoncik, M; Mittermayer, F; Peck-Radosavljevic, M; Pleiner, J; Schaller, G; Wolzt, M | 1 |
| Chia, S; Cruden, NL; Dover, AR; Ferguson, JW; Hayes, PC; Newby, DE | 1 |
| Blaise, G; Vallieres, Y; van Obbergh, L | 1 |
1 trial(s) available for omega-n-methylarginine and Ascites
| Article | Year |
|---|---|
Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
Topics: Angiotensin II; Ascites; Enzyme Inhibitors; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Renin; Sodium; Water | 2003 |
7 other study(ies) available for omega-n-methylarginine and Ascites
| Article | Year |
|---|---|
Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.
Topics: Animals; Ascites; Biomarkers; Carbon Tetrachloride; Endothelial Cells; Endothelium, Lymphatic; Liver Cirrhosis; Lymphatic System; Lymphography; Male; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Random Allocation; Rats; Rats, Wistar | 2013 |
Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis.
Topics: Angiotensin II; Ascites; Case-Control Studies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Forearm; Humans; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Nitric oxide inhibition in cirrhosis and ascites.
Topics: Ascites; Enzyme Inhibitors; Humans; Liver Cirrhosis; Nitric Oxide; omega-N-Methylarginine | 2003 |
Nitric oxide synthesis contributes to inhibition of graft-versus-tumor-effects against intraperitoneal Meth A tumor.
Topics: Animals; Ascites; Blotting, Western; Crosses, Genetic; Enzyme Inhibitors; Female; Graft vs Tumor Effect; Interferon-gamma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Reverse Transcriptase Polymerase Chain Reaction; RNA; Skin Neoplasms | 2004 |
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites.
Topics: Angiotensin II; Antioxidants; Ascites; Ascorbic Acid; Female; Forearm; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norepinephrine; omega-N-Methylarginine; Oxidative Stress; Vasoconstriction; Vasoconstrictor Agents | 2005 |
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.
Topics: Ascites; Dose-Response Relationship, Drug; Female; Forearm; Hemodynamics; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Synthase Type II; Norepinephrine; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasoconstriction | 2006 |
Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related.
Topics: Animals; Ascites; Cardiac Output; Coronary Vessels; Enzyme Inhibitors; Heart Failure; Liver Cirrhosis, Biliary; Male; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1996 |